January 18, 2022

children aged 5 to 11 vaccinated this Wednesday

COVID. The epidemic has reached a level of circulation as high as in last April, with more than 60,000 contaminations detected yesterday. Vaccination of children aged 5 to 11 with co-morbidities has started.

  • This Wednesday, December 15, the coronavirus epidemic is actively circulating, indicators show that the health situation is deteriorating further: more than 63,400 cases of contamination were recorded yesterday according to the official report, the incidence rate is 505, 67 cases per 100,000 inhabitants. If experts and the Ministry of Health have identified an epidemic peak for the next few days, uncertainty remains as to the possibility that the coronavirus in France will weaken: the Omicron variant could strengthen the epidemic in the coming weeks. The detailed report can be found at the bottom of the page.
  • This Wednesday also marks the start of the vaccination campaign for children aged 5 to 11 with comorbidity, with a reduced dose of the Pfizer vaccine. The government is awaiting the opinion of the HAS to decide on the opening of this vaccination campaign to all children.
  • On Tuesday evening, the WHO said Omicron “is spreading at a rate that we have never seen with any other variant.”
  • A South African study made public yesterday shows that the effectiveness of the Pfizer vaccine on severe forms of the Omicron variant is only 70%, raising concerns for the future of the epidemic.
  • While the Christmas holidays are conducive to gatherings, the Scientific Council is alerting the French to the risk that the epidemic will worsen. In his latest opinion, he urges the French to avoid major events “which could lead to giant clusters”, ask to reduce his contacts, not to go out if one is symptomatic, to use antigenic tests and self-tests even if the ‘we are vaccinated and symptom-free before the holidays and to respect barrier gestures even between relatives.

And immediately

09:26 – French Sanofi’s coronavirus vaccine will only be there in a few months

The French laboratory will have to wait before requesting marketing authorization for its Covid-19 vaccine from the European Medicines Agency: Sanofi must include in its studies more sick participants, never infected and never vaccinated, which is more and more difficult. The final results are therefore expected in the first quarter of 2022 The group published this Wednesday morning the interim results of its so-called phase 3 trials of its recombinant protein-based vaccine. “These preliminary data show that we have a strong booster vaccine candidate, regardless of the vaccine administered as a primary vaccination”, commented Thomas Triomphe, head of the vaccines branch of Sanofi. The press release insists on the fact that the French vaccine provides “an increase in neutralizing antibodies, for all vaccines administered as a primary series (mRNA or adenovirus), of the order of 9 to 43 times, in all age groups and with a good safety and tolerance profile “.

08:59 – 360,000 children under 12 can be vaccinated starting today

Children aged 5 to 11 who are now eligible for vaccination in France are just over 360,000; these are those at increased risk of developing a severe form, and those living with immunocompromised or vulnerable people. Children with chronic liver disease, heart disease, or chronic respiratory or neurological disease are affected. Vaccination is also open to children suffering from obesity, diabetes, primary immunodeficiency and children with Down’s syndrome.

08:45 – “Omicron should be going to take over from the fifth wave”

Invited this morning at the microphone of France Inter, infectious disease specialist Odile Launay expressed her fears about the arrival of the Omicron variant, which should strengthen the epidemic when France should experience a little lull. “We are very worried about the arrival of Omicron, which should very probably take place in January and which will take over from the fifth wave linked to the Delta variant. With this virus nobody can make any predictions, but we can do everything have observed what is happening near us, in the UK and in Denmark, it should happen here quickly. […] Even if it is a little less virulent, its gain in terms of transmissibility will very significantly increase the number of contaminations. […] The 3rd dose is essential if we want to be ready for the arrival of this variant “.

Find out more

According to the latest data from Public Health France, communicated Tuesday, December 14, the seven-day average continues to increase and exceeds 49,500 new cases. In the past 24 hours, 158 people have died from Covid-19 in hospital. The incidence rate increased significantly in 24 hours and now by 505.67 new contaminations per 100,000 inhabitants, ie 1.32 points more than the day before. Here is the detailed report:

  • 8,334,133 cases confirmed by PCR (nursing home included), i.e. 63,405 more
  • 120,832 deaths in total (nursing homes included), i.e. 158 more
  • 93,841 deaths in hospital, i.e. 158 more
  • 26,991 deaths in nursing homes (not updated)
  • 14,819 people currently hospitalized, i.e. 292 more
  • 2,792 people currently in intensive care, i.e. 40 more
  • 1,662 new admissions to hospital (+157) and 362 to intensive care (-17)
  • 445,100 people discharged from hospital, i.e. 1,167 more
  • Test positivity rate: 6.61%, i.e. -0.01 point (s) less
  • Incidence rate: 505.67 cases / 100,000, i.e. 1.32 point more

According to the latest epidemiological point of Public Health France (SPF), published Thursday, December 9, “the circulation of SARS-CoV-2, already very intense on the metropolitan territory, continued to progress, with hospitalizations and admissions in critical care still on the rise “. On average, nearly 43,000 cases were diagnosed each day and the incidence rate was 448 positive cases per 100,000 population in many areas – the incidence rate therefore exceeded those of the peaks of Wave 3 and Wave 4.

  • In metropolitan France, the incidence rate increases in week 48 and goes to 448 new cases per 100,000 inhabitants (vs. 312 in W47, or + 44%). The screening rate increased significantly in W48 (6,990/100,000, + 29% compared to W47). The test positivity rate was on the rise (6.4%, vs 5.8% in W47). The corrected incidence rate was sharply increasing in all age groups: the highest rates were observed in 6-10 year olds (988, + 48%), 11-14 year olds (609, + 55% ), 30-39 year olds (628, + 49%) and 40-49 year olds (546, + 46%).
  • The number of hospitalizations on the rise. The indicators by date of admission showed 5,856 new hospitalizations in W48 (+ 27% compared to W47, where 4,612 new hospitalizations were counted) and 1,369 new admissions to critical care services (+ 33% compared to S47, where 1,031 Covid patients were admitted to critical care).
  • The Delta variant of the coronavirus is still the majority in France, more than 99% identified by sequencing during the latest Flash surveys.
  • Vaccination against Covid-19 is still progressing: As of December 7, vaccination coverage from anti-Covid vaccine was estimated at 77.7% of the population for at least one dose, 76.1% for a full vaccination. Among those aged 65 and over, 51.4% had received a booster dose.

Follow the evolution of the coronavirus in your town using the map below. Click on a department to display the list of municipalities. Also find all the details on this mapping and the full point by city and by department in our article on the Covid map in France.

Click on a department to consult the list of its cities.

Since mid-October 2020, Public Health France has been communicating incidence data (number of cases per 100,000 inhabitants) at the municipal level. The figures are at this stage communicated according to a scale (10, 20, 50, 150, 250, 500, 1000 cases per 100,000 inhabitants). The data are expressed on a rolling week, which means that they are calculated on a day D from the tests carried out between 3 and 9 days previously. To access information relating to the coronavirus in your town, enter its name into the search engine or click on its department in the map below.

As a reminder, the incidence rate corresponds to the number of new cases of Covid-19 over a period of one week, compared to the total population of a territory (country, region, department or municipality). This indicator is generally expressed in number of cases per 100,000 inhabitants. The screening rate gives the number of people who have tested for the coronavirus out of the total number of inhabitants, during the period. It is also expressed most often on 100,000 inhabitants. Finally, the test positivity rate gives the percentage of positive tests for the coronavirus, compared to the total number of tests carried out over the period.